7.66
price up icon5.95%   0.43
after-market After Hours: 7.94 0.28 +3.66%
loading
Precision Biosciences Inc stock is traded at $7.66, with a volume of 297.67K. It is up +5.95% in the last 24 hours and up +35.10% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
See More
Previous Close:
$7.23
Open:
$7.3
24h Volume:
297.67K
Relative Volume:
1.11
Market Cap:
$197.65M
Revenue:
$34.26M
Net Income/Loss:
$-46.61M
P/E Ratio:
-1.4786
EPS:
-5.1806
Net Cash Flow:
$-62.01M
1W Performance:
+27.88%
1M Performance:
+35.10%
6M Performance:
+17.85%
1Y Performance:
+38.77%
1-Day Range:
Value
$6.96
$7.69
1-Week Range:
Value
$5.96
$7.69
52-Week Range:
Value
$3.53
$8.82

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
Name
Precision Biosciences Inc
Name
Phone
919-314-5512
Name
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Name
Employee
68
Name
Next Earnings Date
2026-03-12
Name
Latest SEC Filings
Name
DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
DTIL icon
DTIL
Precision Biosciences Inc
7.66 186.56M 34.26M -46.61M -62.01M -5.1806
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Upgrade BMO Capital Markets Market Perform → Outperform
Apr-30-24 Initiated Guggenheim Buy
Jun-17-22 Initiated BMO Capital Markets Outperform
Jun-09-22 Downgrade William Blair Outperform → Mkt Perform
Jul-27-20 Resumed BTIG Research Buy
Apr-03-20 Downgrade Goldman Buy → Neutral
Mar-05-20 Initiated Stifel Buy
Feb-25-20 Initiated William Blair Outperform
Aug-09-19 Initiated BTIG Research Buy
Jul-16-19 Initiated H.C. Wainwright Buy
Apr-22-19 Initiated Barclays Overweight
Apr-22-19 Initiated Goldman Buy
Apr-22-19 Initiated JP Morgan Overweight
Apr-22-19 Initiated Jefferies Buy
View All

Precision Biosciences Inc Stock (DTIL) Latest News

pulisher
03:15 AM

Precision BioSciences (DTIL) surpasses Q4 earnings and revenue estimates - MSN

03:15 AM
pulisher
12:42 PM

Precision BioSciences Expands ELIMINATE-B Trial to Europe - National Today

12:42 PM
pulisher
11:00 AM

Precision BioSciences (DTIL) Expands Hepatitis B Trial to Europe - GuruFocus

11:00 AM
pulisher
10:30 AM

Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - BioSpace

10:30 AM
pulisher
09:46 AM

Empery Asset Management, Ryan M. Lane (DTIL) disclose 7.63% ownership - Stock Titan

09:46 AM
pulisher
Apr 14, 2026

Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study - MSN

Apr 14, 2026
pulisher
Apr 14, 2026

Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance

Apr 14, 2026
pulisher
Apr 14, 2026

DTIL Options Volatility — NASDAQ:DTIL - TradingView — Track All Markets

Apr 14, 2026
pulisher
Apr 14, 2026

DTIL Options Chain — NASDAQ:DTIL - TradingView — Track All Markets

Apr 14, 2026
pulisher
Apr 13, 2026

Jobs Data: How does Precision BioSciences Inc compare to its peersStock Surge & Verified High Yield Trade Plans - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

How does Precision BioSciences Inc compare to its peersWeekly Market Summary & AI Forecasted Stock Moves - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

DTIL Price Today: Precision BioSciences, Inc. Stock Price, Quote & Chart - MEXC

Apr 10, 2026
pulisher
Apr 08, 2026

Precision BioSciences to Attend Healthcare Conference - National Today

Apr 08, 2026
pulisher
Apr 08, 2026

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 08, 2026
pulisher
Apr 08, 2026

Precision BioSciences (NASDAQ: DTIL) details equity plan, charter change in 2026 proxy - Stock Titan

Apr 08, 2026
pulisher
Apr 07, 2026

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Apr 07, 2026
pulisher
Apr 06, 2026

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Apr 06, 2026
pulisher
Apr 04, 2026

Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 04, 2026
pulisher
Mar 30, 2026

Precision Biosciences Shares Face Significant Pressure Amid Market Skepticism () - aktiencheck.de

Mar 30, 2026
pulisher
Mar 30, 2026

Quarterly Recap: What is the long term forecast for Precision BioSciences Inc stockExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 28, 2026

FOMO Trade: How does Precision BioSciences Inc perform in inflationary periodsPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 28, 2026

Aug Action: Is Precision BioSciences Inc stock trending bullishInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 27, 2026

3.8M-share increase, director elections and charter change at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

Will Precision BioSciences Inc be affected by tariffs2026 Biggest Moves & Growth Focused Entry Point Reports - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

VIX Spike: How does Precision BioSciences Inc compare to its peersQuarterly Risk Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Decliners Report: Is Rafael Holdings Inc Equity Warrant stock a good dividend stockProduct Launch & Safe Swing Trade Setups - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

Meme Stocks: What is the PEG ratio of Precision BioSciences Inc2026 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn

Mar 24, 2026
pulisher
Mar 24, 2026

Precision BioSciences (DTIL) Expected to Announce Earnings on Tuesday - MarketBeat

Mar 24, 2026
pulisher
Mar 23, 2026

Q1 EPS Estimate for Precision BioSciences Raised by Analyst - MarketBeat

Mar 23, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Precision Biosciences (DTIL) - Stock Titan

Mar 21, 2026
pulisher
Mar 21, 2026

Growth Value: How does Precision BioSciences Inc compare to its peers2026 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Brokers Set Expectations for DTIL Q1 Earnings - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

ETFs Investing in Precision BioSciences, Inc. Stocks - TradingView

Mar 20, 2026
pulisher
Mar 18, 2026

Portfolio Recap: Is Precision BioSciences Inc likely to announce a buybackTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Precision BioSciences, Inc. (DTIL) Shareholder/Analyst CallSlideshow (NASDAQ:DTIL) 2026-03-18 - Seeking Alpha

Mar 18, 2026
pulisher
Mar 18, 2026

Jones Trading reiterates Precision BioSciences stock rating on DMD trial design - Investing.com Canada

Mar 18, 2026
pulisher
Mar 18, 2026

Jones Trading reiterates Precision BioSciences stock rating on DMD trial design By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 18, 2026

FDA puts infant gene therapy ECUR-506 in rare CMC pilot to speed manufacturing talks - Stock Titan

Mar 18, 2026
pulisher
Mar 17, 2026

Precision BioSciences Announces PBGENE-DMD Investor Update and Highlights ARCUS Gene Editing Platform – March 2026 - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

Precision BioSciences Highlights PBGENE-DMD Program and Trial - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Mar 17, 2026
pulisher
Mar 16, 2026

Quarterly Risk: How volatile is Precision BioSciences Inc stockEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Precision BioSciences (DTIL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 15, 2026
pulisher
Mar 14, 2026

Precision BioSciences Stock (ISIN: US74019P1084) Surges on Q4 Profit Turnaround Amid Analyst Upgrade - AD HOC NEWS

Mar 14, 2026
pulisher
Mar 14, 2026

Jefferies cuts Precision BioSciences stock price target on valuation - Investing.com India

Mar 14, 2026
pulisher
Mar 14, 2026

Precision BioSciences (NASDAQ:DTIL) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative - simplywall.st

Mar 13, 2026
pulisher
Mar 13, 2026

Precision BioSciences Inc buy Jefferies Financial Group Inc. - sharewise.com

Mar 13, 2026
pulisher
Mar 13, 2026

Jefferies cuts Precision BioSciences stock price target on valuation By Investing.com - Investing.com Australia

Mar 13, 2026
pulisher
Mar 13, 2026

DTIL SEC FilingsPrecision Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy - TipRanks

Mar 13, 2026

Precision Biosciences Inc Stock (DTIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Cap:     |  Volume (24h):